We are live on ! Find out more
ETON icon

Eton Pharmaceutcials

50 hedge funds and large institutions have $28.8M invested in Eton Pharmaceutcials in 2023 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 10 increasing their positions, 5 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

4,125% more call options, than puts

Call options by funds: $338K | Put options by funds: $8K

340% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 5

100% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 5

52% more funds holding

Funds holding: 3350 (+17)

38% more capital invested

Capital invested by funds: $20.9M → $28.8M (+$7.91M)

3.46% more ownership

Funds ownership: 23.44%26.9% (+3.5%)

Holders
50
Holders Change
+17
Holders Change %
+51.52%
% of All Funds
0.79%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
22
Increased
10
Reduced
5
Closed
5
Calls
$338K
Puts
$8K
Net Calls
+$330K
Net Calls Change
+$92K
Name Holding Trade Value Shares
Change
Change in
Stake
OM
1
Opaleye Management
Massachusetts
$10.1M +$561K +145,270 +6%
Vanguard Group
2
Vanguard Group
Pennsylvania
$4.07M
WIM
3
Westside Investment Management
California
$2.2M +$35K +9,059 +2%
PCMI
4
Paradigm Capital Management Inc
New York
$1.25M
BlackRock
5
BlackRock
New York
$1.19M -$50.4K -13,049 -4%
BCM
6
Bridgeway Capital Management
Texas
$1.13M +$116K +30,000 +12%
EI
7
EAM Investors
California
$1.07M +$991K +256,623 New
AI
8
Acuitas Investments
Washington
$913K -$1.12M -291,054 -57%
Geode Capital Management
9
Geode Capital Management
Massachusetts
$908K +$29.1K +7,537 +4%
Ameriprise
10
Ameriprise
Minnesota
$778K +$720K +186,562 New
PHP
11
Parkman Healthcare Partners
Connecticut
$688K +$637K +165,000 New
EIM
12
Essex Investment Management
Massachusetts
$459K +$166K +43,095 +64%
Acadian Asset Management
13
Acadian Asset Management
Massachusetts
$403K +$375K +97,264 New
State Street
14
State Street
Massachusetts
$339K +$40.1K +10,400 +15%
Millennium Management
15
Millennium Management
New York
$335K +$310K +80,320 New
Two Sigma Investments
16
Two Sigma Investments
New York
$332K +$307K +79,552 New
Bank of New York Mellon
17
Bank of New York Mellon
New York
$331K
Jane Street
18
Jane Street
New York
$272K +$252K +65,210 New
Squarepoint
19
Squarepoint
New York
$186K +$118K +30,609 +218%
SSA
20
Schonfeld Strategic Advisors
New York
$182K +$168K +43,600 New
Renaissance Technologies
21
Renaissance Technologies
New York
$180K +$60.2K +15,600 +57%
Connor, Clark & Lunn Investment Management (CC&L)
22
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$160K +$148K +38,305 New
Northern Trust
23
Northern Trust
Illinois
$156K +$17.6K +4,564 +14%
William Blair & Company
24
William Blair & Company
Illinois
$154K
HIM
25
Hillsdale Investment Management
Ontario, Canada
$120K +$111K +28,800 New

ETON Hedge Fund Activity: Q3 2023 in Review

50 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Eton Pharmaceutcials (ETON) for Q3 2023, worth a combined $28.8M — up 38% from $20.9M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new ETON positions and 5 closed out — a net gain of 17 holders — while 10 added to existing stakes and 5 trimmed.

The largest buyer was EAM Investors, opening a new position worth an estimated $991K. The largest seller was Acuitas Investments, cutting an estimated $1.12M.

  • 50 institutional investors held Eton Pharmaceutcials (ETON) as of Q3 2023, up from 33 in Q2 2023.
  • Funds reported $28.8M of Eton Pharmaceutcials stock for Q3 2023, up 38% quarter-over-quarter.
  • 22 funds opened new Eton Pharmaceutcials positions in Q3 2023 and 5 closed out, a net change of +17 holders.
  • The largest Eton Pharmaceutcials buyer in Q3 2023 was EAM Investors, an estimated $991K added.
  • The largest Eton Pharmaceutcials seller in Q3 2023 was Acuitas Investments, an estimated $1.12M sold.

Based on aggregated 13F filings for Q3 2023.